United Kingdom · Question · Written question
UIN 110593
Idiopathic Pulmonary Fibrosis: Drugs
Introduced
3 February 2026
Last action
12 February 2026 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
12 February 2026
Summary
To ask the Secretary of State for Health and Social Care, whether his Department has considered the implications of the UK-US Economic Prosperity Deal for the potential approval of Jascayd (nerandomilast).
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
3 February 2026
Written question
To ask the Secretary of State for Health and Social Care, whether his Department has considered the implications of the UK-US Economic Prosperity Deal for the potential approval of Jascayd (nerandomilast).
Source: Commons
12 February 2026
Answer
No specific consideration of the implications of the United Kingdom and United States’ Economic Prosperity Deal for the approval of Jascayd (nernadomilast) has been made. The changes that we are making to the way in which the National Institute for Health...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2026-02-03/110593
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1877896
- uk · wq-1877896 · source updated 12 February 2026